Lenacapavir injection offers 100% HIV protection to young women

Hindustan Times July 7, 2024, 03:00 PM UTC

Summary: A clinical trial in South Africa and Uganda showed that lenacapavir injection offers total protection against HIV for young women, with a 100% efficiency rate. The trial compared lenacapavir to two other PrEP drugs, Truvada and Descovy. The breakthrough could significantly impact HIV prevention efforts, especially for populations at high risk. The drug's rollout is pending regulatory approvals and WHO recommendations. Price and accessibility are crucial considerations for widespread adoption.

Full article

Article metrics
Significance5.8
Scale7.0
Magnitude8.0
Novelty9.0
Actionability6.0
Immediacy7.0
Positivity9.0
Probability8.0
Credibility7.3

Timeline:

  1. [4.4]
    Biannual lenacapavir injection 100% effective in preventing HIV (News Karnataka)
    23h
    Source
  2. [5.1]
    UNAIDS urges global access to new HIV drug Lenacapavir (Marketscreener.com)
    4d

  3. [6.3]
    New HIV prevention drug lenacapavir shows 100% efficacy (ScienceAlert)
    5d

  4. [4.6]
    Biannual Lenacapavir injection 100% effective against HIV (WION)
    7d
    Source
  5. [5.2]
    HIV prevention drug lenacapavir safe and effective in trial (The East African)
    9d

  6. [6.1]
    HIV prevention injection successful in South Africa trial (AllAfrica - Top Africa News)
    14d